Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

PepsiCo is drifting well to the sleep aid industry

PepsiCo is drifting well to the sleep aid industry

PepsiCo to launch Driftwell – a sleep-aid drink

PepsiCo, the food and beverage company, seems to have found a way to reap the pandemic's benefits in the long term.

PepsiCo announced a new addition to the "functional beverage" category available for purchase starting December – Driftwell. First, it will be available online and beginning in 2021, in stores. The beverage's purpose is to help consumers relax and sleep. The drink is said to contain L-theanine, a substance found in tea, and it eases anxiety and improves mental function, as the company aims to have a functional beverage that could "hit that sweet spot in the middle."

However, in the past few years, PepsiCo has been looking to secure its position in the #health and #wellness sectors by purchasing KeVita – a kombucha beverage maker, and Health Warrior – a plant-based energy bar company.

The release time comes when many consumers are reporting sleeping trouble caused by anxiety that's pandemic-driven.

PepsiCo is trying to take a dip in the $1 billion over-the-counter sleep aid and relaxation markets, but it is not the first major company to do so. Coca-Cola launched Coca-Cola Energy with B-vitamins and various flavors, and caffeine.

Molson-Coors Beverage Co. launched Vizzy – a sparkling seltzer with vitamin C, and it's getting ready to hit the shelves with MadVine and Golden Wing.

Year-to-date, PepsiCo stock price broke even, while USA500 added 4.7%.

Read more financial news on CAPEX.com!

Sources: edition.cnn.com, marketwatch.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com